Table 1 of Xiao, Mol Vis 2019; 25:821-833.


Table 1. Clinical information of the probands and affected siblings with biallelic SPATA7 mutations.

Family
ID Clinic
group Mutation based on
NM_018418 Effect Gender Age (year) at Axial length/
refraction First
symptom Visual acuity Fundus
changes ERG recording
rods and cones
onset 1st exam right left
F01-II:1* LCA c.[1183C>T];[1183C>T] p.[R395*];[R395*] M 0.3 0.6 NA PV, ODS, RN NPL NPL AV, YFD Extinguished
F02-II:1 LCA c.[367C>T];[1183C>T] p.[Q123*];[R395*] F FMB 4.3 +5.25; +5.75 PV, RV LP LP AV, TD NA
F03-II:1* LCA c.[644_647del];[644_647del] p.[L215Sfs*];[L215Sfs*] F FMB 2.3 NA PV, ODS, RN LP LP AV, YSB Extinguished
F03-II:2 LCA c.[644_647del];[644_647del] p.[L215Sfs*];[L215Sfs*] M FMB 1.3 NA PV, ODS, RN LP LP AV, YSB NA
F04-II:1* LCA c.[1183C>T];[1183C>T] p.[R395*];[R395*] M 0.583333 1.3 NA PV, ODS, RN NPL NPL AV, TD Extinguished
F05-II:1 LCA c.[367C>T];[367C>T] p.[Q123*];[Q123*] F FMB 13 NA PV, RN LP LP AV, YMD, PPP Extinguished
F06-II:1 LCA c.[322C>T];[322C>T] p.[R108*];[R108*] M 0.3 2.4 +5.00; +4.75 PV, RV LP LP normal-like Extinguished
F07-II:1* jRP c.[322C>T];[1183C>T] p.[R108*];[R395*] M FMB 3.4 -1.50; -1.25 PV, NB, PA 0.4 0.6 AV, YMD, PPP Extinguished
F08-II:1 jRP c.[20_23del];[1183C>T] p.[V7Efs*19];[R395*] M 4 7 +3.00;+2.50 PV, NYS 0.02 0.03 AV, YMD, PPP Extinguished
F09-II:6 jRP c.[20_23del];[1083-2A>G] p.[V7Efs*19];[splicing] M 22 25 NA NB HM LP WPD, AV, IBP NA
F10-II:1 myopia c.[20_23del];[20_23del] p.[V7Efs*19];[V7Efs*19] M NA 5 -8.50; -10.25 PV NA NA NA NA
F10-II:2 myopia c.[20_23del];[20_23del] p.[V7Efs*19];[V7Efs*19] M NA 3 24.38; 23.91mm PV NA NA NA NA